Man Group
HRMY icon

Man Group’s Harmony Biosciences HRMY Stock Holding History

Man Group’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.19M Sell
142,443
-319,455
-69% -$10.1M 0.01% 1121
2026
Q1 		$12.9M Buy
461,898
+155,155
+51% +$5.09M 0.02% 698
2025
Q4 		$11.5M Buy
306,743
+29,681
+11% +$976K 0.02% 732
2025
Q3 		$7.64M Buy
277,062
+24,443
+10% +$842K 0.01% 908
2025
Q2 		$7.98M Buy
252,619
+65,252
+35% +$2.1M 0.02% 865
2025
Q1 		$6.22M Sell
187,367
-26,746
-12% -$959K 0.02% 926
2024
Q4 		$7.37M Buy
214,113
+58,642
+38% +$2.01M 0.02% 851
2024
Q3 		$6.22M Sell
155,471
-2,127
-1% -$74.7K 0.02% 946
2024
Q2 		$4.75M Buy
157,598
+13,039
+9% +$392K 0.01% 1026
2024
Q1 		$4.85M Buy
144,559
+5,215
+4% +$167K 0.01% 1006
2023
Q4 		$4.5M Buy
+139,344
New +$3.89M 0.01% 985
2023
Q3 		– Sell
-318,899
Closed -$11.1M – 1028
2023
Q2 		$11.2M Buy
+318,899
New +$11M 0.03% 585
2023
Q1 		– Sell
-237,002
Closed -$10.8M – 806
2022
Q4 		$13.1M Sell
237,002
-32,622
-12% -$1.79M 0.05% 467
2022
Q3 		$11.9M Buy
+269,624
New +$13.2M 0.06% 420
2022
Q2 		– Sell
-117,970
Closed -$5.31M – 477
2022
Q1 		$5.74M Buy
117,970
+101,329
+609% +$4.13M 0.02% 834
2021
Q4 		$710K Buy
16,641
+10,411
+167% +$415K ﹤0.01% 1427
2021
Q3 		$239K Buy
+6,230
New +$201K ﹤0.01% 1710

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group's HRMY Position: Q2 2026 in Review

Man Group reduced its Harmony Biosciences (HRMY) stake by 69% in Q2 2026, selling an estimated $10.1M and leaving 142,443 shares worth $5.19M. The position accounts for 0.01% of the portfolio, ranked #1121.

Man Group first reported a position in HRMY in Q3 2021 and has held it in 17 quarters since. The position peaked at $13.1M in Q4 2022. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Man Group held 142,443 shares of Harmony Biosciences worth $5.19M as of Q2 2026.
  • Man Group sold 319,455 Harmony Biosciences shares in Q2 2026, an estimated $10.1M.
  • Harmony Biosciences made up 0.01% of Man Group's portfolio in Q2 2026, its #1121 holding.
  • Man Group first reported a position in Harmony Biosciences in Q3 2021 and has held it in 17 quarters since.
  • Man Group's Harmony Biosciences position peaked at $13.1M in Q4 2022.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.